RadNet, a provider of fixed-site outpatient diagnostic imaging services through a network of 350 owned and operated outpatient imaging centers, acquired two unrelated Dutch technology companies, Aidence Holding B.V., a radiology artificial intelligence company focusing on clinical solutions for pulmonary nodule management and lung cancer screening, and Quantib B.V., a leading radiology AI and machine learning company focusing on clinical solutions for prostate cancer and neurodegeneration.
When combined with RadNet’s existing DeepHealth mammography AI division, the two acquisitions provide RadNet with the basis for future offerings for widespread cancer screening programs for the three most prevalent cancers (breast, prostate and lung). Read more.
